ECTRIMS/EAN Statement on COVID-19 Vaccination in MS Patients ECTRIMS/EAN Statement on COVID-19 Vaccination in MS Patients
The statement concludes that COVID-19 vaccines are safe for patients with multiple sclerosis and that most MS patients gain the same protection as the general population. But there are exceptions.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 15, 2021 Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news

Ublituximab Improves Functional MS Score: New ULTIMATE Analysis Ublituximab Improves Functional MS Score: New ULTIMATE Analysis
The new anti-CD20 monoclonal antibody showed significant improvement in the multiple sclerosis functional composite (MSFC) score, a measure of disability, compared with teriflunomide.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 15, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder
Basel, 14 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new longer-term efficacy and safety data for ENSPRYNG® (satralizumab). The data show ENSPRYNG has a favourable benefit:risk profile and is effective in reducing relapses over four years of treatment in people with anti-aquaporin-4 antibody (AQP 4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), a rare debilitating disease that affects the central nervous system. Efficacy and safety results from the open-label extension (OLE) periods of the SAkuraStar and SAkuraSky studies, in addition to the design of SAkuraBONSAI, a new ...
Source: Roche Media News - October 14, 2021 Category: Pharmaceuticals Source Type: news

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder
Basel, 14 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new longer-term efficacy and safety data for ENSPRYNG® (satralizumab). The data show ENSPRYNG has a favourable benefit:risk profile and is effective in reducing relapses over four years of treatment in people with anti-aquaporin-4 antibody (AQP 4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), a rare debilitating disease that affects the central nervous system. Efficacy and safety results from the open-label extension (OLE) periods of the SAkuraStar and SAkuraSky studies, in addition to the design of SAkuraBONSAI, a new ...
Source: Roche Investor Update - October 14, 2021 Category: Pharmaceuticals Source Type: news

Selma Blair Wants You to See Her Living With Multiple Sclerosis
The actress puts herself out there in “Introducing, Selma Blair,” an unflinching documentary that she hopes can help others. (Source: NYT Health)
Source: NYT Health - October 13, 2021 Category: Consumer Health News Authors: Dave Itzkoff Tags: Content Type: Personal Profile Multiple Sclerosis Documentary Films and Programs Actors and Actresses Cruel Intentions (Movie) Legally Blonde (Movie) Introducing, Selma Blair (Movie) Blair, Selma Gellar, Sarah Michelle Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Media News - October 13, 2021 Category: Pharmaceuticals Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Investor Update - October 13, 2021 Category: Pharmaceuticals Source Type: news

Identification of modified dynamic gait index cutoff scores for assessing fall risk in people with Parkinson disease, stroke and multiple sclerosis - Torchio A, Corrini C, Anastasi D, Parelli R, Meotti M, Spedicato A, Groppo E, D'Arma A, Grosso C, Montesano A, Cattaneo D, Gervasoni E.
BACKGROUND: Balance and gait impairments increase fall rate and injury in people with neurological disorders(PwND). The modified Dynamic Gait Index(mDGI) is a scale assessing dynamic balance during walking, however its ability in identifying Fallers and Re... (Source: SafetyLit)
Source: SafetyLit - October 12, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

ClearSky Health announces plans to build rehabilitation hospital in Waxahachie
ClearSky Rehabilitation Hospital of Waxahachie will offer rehabilitative and specialized care to about 650 patients living with disabling injuries and other diseases such as hip fractures, brain injuries, stroke, spinal injuries and multiple sclerosis. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 11, 2021 Category: Biotechnology Authors: Plamedie Ifasso Source Type: news

ClearSky Health announces plans to build rehabilitation hospital in Waxahachie
Rehabilitative healthcare provider  ClearSky Health announced Friday it plans to build a 30-bed medical rehabilitation hospital in Waxahachie, Texas.  ClearSky Rehabilitation Hospital of Waxahachie will offer rehabilitative and specialized care to about 650 patients living with disabling injuries and other diseases such as h ip fractures, brain injuries, stroke, spinal injuries and multiple sclerosis.   “The facility will be a great addition to our medical community in meeting our citizens’… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 11, 2021 Category: American Health Authors: Plamedie Ifasso Source Type: news

Free from falls education and exercise program for reducing falls in people with multiple sclerosis: a randomized controlled trial - Cameron MH, Hildebrand A, Hugos CL, Judd GI, McMillan G, Jacobs PG.
BACKGROUND: People with multiple sclerosis (PwMS) fall frequently. Community-delivered exercise and education reduce falls in older adults, but their efficacy in multiple sclerosis (MS) is unknown. OBJECTIVES: To evaluate the impact of the Free Fro... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Good News for MS Diagnosis, Prognosis Good News for MS Diagnosis, Prognosis
Twenty-five year data show a positive shift towards earlier diagnosis and treatment of multiple sclerosis and improved prognosis over time.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 7, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS ® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) from 13 - 15 October 2021. These data include 38 abstracts highlighting new longer-term efficacy and safety for both OCREVUS and ENSPRYNG, as well as our ongoing efforts to evaluate the impact of the COVID-19 pandemic for people living with MS. Additional data will show how a deeper scientific understanding of MS and NMOSD in diverse patient populations ...
Source: Roche Investor Update - October 5, 2021 Category: Pharmaceuticals Source Type: news

Roche to present new data on OCREVUS in multiple sclerosis and ENSPRYNG in neuromyelitis optica spectrum disorder at ECTRIMS 2021
Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS ® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) from 13 - 15 October 2021. These data include 38 abstracts highlighting new longer-term efficacy and safety for both OCREVUS and ENSPRYNG, as well as our ongoing efforts to evaluate the impact of the COVID-19 pandemic for people living with MS. Additional data will show how a deeper scientific understanding of MS and NMOSD in diverse patient populations ...
Source: Roche Media News - October 5, 2021 Category: Pharmaceuticals Source Type: news

What Causes Facial Pain?
Discussion Dental caries are one of the most common infections. It is usually caused by Streptococcus viridans. Dental caries are also quite preventable with brushing the teeth at least twice a day with a fluoridated dentifrice, use of dental floss, and preventative dental appointments with application of fluoride varnish and sealants as appropriate. Fluoridated water supplies also help. A review can be found here. Facial pain is often acute, self-limited and etiologies that may be obvious such as trauma or infection. Facial pain can also overlap with cranial pain (mainly headache), neck pain (often lymphadenopathy or musc...
Source: PediatricEducation.org - October 4, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Biogen sued over kickback allegations involving MS drugs
Humana alleges that the pharma company improperly pushed those that took its multiple sclerosis drugs onto public health plans and then improperly induced payments from health plans by paying patient copays. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 29, 2021 Category: American Health Authors: Chris Larson Source Type: news

Biogen sued over kickback allegations involving MS drugs
Humana alleges that the pharma company improperly pushed those that took its multiple sclerosis drugs onto public health plans and then improperly induced payments from health plans by paying patient copays. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 29, 2021 Category: Biotechnology Authors: Chris Larson Source Type: news

Humana files another lawsuit against a big pharma company
Humana alleges that the pharma company improperly pushed those that took its multiple sclerosis drugs onto public health plans and then improperly induced payments from health plans by paying patient copays. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 29, 2021 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

Deep Grey Matter Injury in MS: A NAIMS Consensus Statement Deep Grey Matter Injury in MS: A NAIMS Consensus Statement
The NAIMS Cooperative has released a consensus statement regarding the relevance of deep grey matter damage in multiple sclerosis.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

< a href= " /news-events/nih-research-matters/cellular-map-brain-lesions-multiple-sclerosis " > A cellular map of brain lesions in multiple sclerosis < /a >
Researchers created a detailed map of cells in the expanding lesions involved in more disabling forms of multiple sclerosis. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 28, 2021 Category: Consumer Health News Source Type: news

Early symptoms of Multiple Sclerosis: The six warning signs of MS
MULTIPLE SCLEROSIS currently affects over 100,000 people in Britain. How can you spot the early symptoms of MS? Here's what to look out for. (Source: Daily Express - Health)
Source: Daily Express - Health - September 27, 2021 Category: Consumer Health News Source Type: news

Comparing fall detection methods in people with multiple sclerosis: a prospective observational cohort study - Hildebrand A, Jacobs PG, Folsom JG, Mosquera-Lopez C, Wan E, Cameron MH.
This study compares the sen... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

What does evidence tell us about the use of gait robotic devices in patients with multiple sclerosis? A comprehensive systematic review on functional outcomes and clinical recommendations - Calabr ò RS, Cassio A, Mazzoli D, Andrenelli E, Bizzarini E, Campanini I, Carmignano SM, Cerulli S, Chisari C, Colombo V, Dalise S, Fundarò C, Gazzotti V, Mazzoleni D, Mazzucchelli M, Melegari C, Merlo A, Stampacchia G, Boldrini P, Mazzoleni S, Posteraro F, Benanti P, Castelli E, Draicchio F, Falabella V , Galeri S, Gimigliano F, Grigioni M, Mazzon S, Molteni F, Petrarca M, Picelli A, Senatore M, Turchetti G, Morone G, Bonaiuti D.
INTRODUCTION: There is growing evidence on the efficacy of gait robotic rehabilitation in patients with multiple sclerosis (MS), but most of the studies have focused on gait parameters. Moreover, clear indications on the clinical use of robotics still lack... (Source: SafetyLit)
Source: SafetyLit - September 24, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

The Latest on Multiple Sclerosis and COVID-19 Vaccines The Latest on Multiple Sclerosis and COVID-19 Vaccines
Dr Stephen Krieger on how effective vaccines are in these patients, who should receive boosters, and when.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 23, 2021 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

NIH scientists build a cellular blueprint of multiple sclerosis lesions
Study lays the groundwork for potential new therapies for progressive multiple sclerosis. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 10, 2021 Category: American Health Source Type: news

NIH scientists build a cellular blueprint of multiple sclerosis lesions
Chronic lesions with inflamed rims, or "smoldering" plaques, in the brains of people with multiple sclerosis (MS) have been linked to more aggressive and disabling forms of the disease. Using brain tissue from humans, researchers at the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS) built a detailed cellular map of chronic MS lesions, identifying genes that play a critical role in lesion repair and revealing potential new therapeutic targets for progressive MS. (Source: World Pharma News)
Source: World Pharma News - September 10, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

High-Efficacy Therapy Bests Treatment Escalation in MS High-Efficacy Therapy Bests Treatment Escalation in MS
Patients with multiple sclerosis who start highly effective treatment soon after diagnosis have better long-term outcomes than patients who escalate treatment, new research suggests.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 3, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

MS Plus Depression May Up Risk for Death, Vascular Disease MS Plus Depression May Up Risk for Death, Vascular Disease
The effects of depression and multiple sclerosis on all-cause mortality"are synergistic," investigators note."The take-home message...is the importance of treating depression in this population."Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 2, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Depression, MS May Have Synergistic Effect on Mortality Risk
THURSDAY, Sept. 2, 2021 -- Depression in multiple sclerosis (MS) may increase the risks for incident vascular disease and mortality, and the effects of depression and MS on all-cause mortality appear to be synergistic, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 2, 2021 Category: Pharmaceuticals Source Type: news

Depression Can Be a Killer for People With MS
THURSDAY, Sept. 2, 2021 -- Depression and multiple sclerosis (MS) tend to travel together, new research finds, and when they do the chances of dying during the next decade can be up to five times greater than it is for those with neither... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 2, 2021 Category: General Medicine Source Type: news

Cluster of Symptoms Common in People First Diagnosed With MS
MONDAY, Aug. 30, 2021 -- A number of symptoms are common among people who are newly diagnosed with multiple sclerosis, a patient survey shows. Multiple sclerosis (MS) is an incurable disease in which the nerves'protective layers are damaged,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 30, 2021 Category: General Medicine Source Type: news

MRI a Poor Disability Predictor in Secondary Progressive MS MRI a Poor Disability Predictor in Secondary Progressive MS
MRI measures have a weak and variable link to disability in patients with secondary progressive multiple sclerosis, new research suggests. However, newer measures may better reflect outcomes.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 27, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

Schools Across the U.S. Are Already Switching Back to Remote Learning Amid COVID-19 Surge
(ATLANTA) — A few weeks into the new school year, growing numbers of U.S. districts have halted in-person learning or switched to hybrid models because of rapidly mounting coronavirus infections. More than 80 school districts or charter networks have closed or delayed in-person classes for at least one entire school in more than a dozen states. Others have sent home whole grade levels or asked half their students to stay home on hybrid schedules. The setbacks in mostly small, rural districts that were among the first to return dampen hopes for a sustained, widespread return to classrooms after two years of schooling ...
Source: TIME: Health - August 25, 2021 Category: Consumer Health News Authors: Jeff Amy/AP Tags: Uncategorized Education healthscienceclimate wire Source Type: news

Pain, Fatigue, Depression, Anxiety Prevalent After MS Diagnosis
TUESDAY, Aug. 24, 2021 -- Pain, fatigue, depression, and anxiety are prevalent in the year following diagnosis with multiple sclerosis (MS)/clinically isolated syndrome, according to a study recently published in Multiple Sclerosis Journal. Thomas... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 24, 2021 Category: Pharmaceuticals Source Type: news

Identifying falls remotely in people with multiple sclerosis - Block VJ, Pitsch EA, Gopal A, Zhao C, Pletcher MJ, Marcus GM, Olgin JE, Hollenbach J, Bove R, Cree BAC, Gelfand JM.
BACKGROUND: Falling is common in people with multiple sclerosis (MS) but tends to be under-ascertained and under-treated. OBJECTIVE: To evaluate fall risk in people with MS. METHODS: Ninety-four people with MS, able to walk  > 2 min wit... (Source: SafetyLit)
Source: SafetyLit - August 20, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

New Clues to Why Disability Strikes People With MS
FRIDAY, Aug. 20, 2021 -- A new study may help explain why people with multiple sclerosis (MS) experience worsening disability while those with two related diseases do not. MS causes permanent brain and spinal cord scarring, and researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 20, 2021 Category: General Medicine Source Type: news

Amy Winehouse's mum backs campaign for life-changing MS drug
JANIS Winehouse - mother of late singer Amy - has backed our crusade to end a shameful postcode lottery for access to the multiple sclerosis drug Sativex. (Source: Daily Express - Health)
Source: Daily Express - Health - August 19, 2021 Category: Consumer Health News Source Type: news

End scandal of postcode lottery for vital MS drug
THOUSANDS of patients with multiple sclerosis are being denied access to a life-changing medicine that can reduce painful muscle spasms. The cannabis-based drug Sativex is approved for use on the NHS but patchy funding across England means many sufferers are unable to get a prescription. (Source: Daily Express - Health)
Source: Daily Express - Health - August 18, 2021 Category: Consumer Health News Source Type: news

Selma Blair Reports Multiple Sclerosis Remission Selma Blair Reports Multiple Sclerosis Remission
Actress Selma Blair has reported that she's now in remission after years of a serious multiple sclerosis flare.WebMD Health News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 17, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Validity of 2 fall prevention strategy scales for people with stroke, Parkinson's disease, and multiple sclerosis - Gervasoni E, Beghi E, Corrini C, Parelli R, Bianchi E, Mestanza Mattos FG, Jonsdottir J, Montesano A, Cattaneo D.
This study investigated the ceiling and floor... (Source: SafetyLit)
Source: SafetyLit - August 17, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Selma Blair says she's 'in remission' from multiple sclerosis: 'My prognosis is great'
Selma Blair said it's a result of undergoing hematopoietic stem-cell transplantation. (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2021 Category: Consumer Health News Source Type: news

Selma Blair reveals she's currently in remission from her multiple sclerosis battle
Selma, 49, who went public with her diagnosis of the autoimmune disease in October 2018 - gave the health update when appearing... (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2021 Category: Consumer Health News Source Type: news

CCM can identify nerve damage in patients with long COVID, new study finds
The non-invasive eye examination is also used to identify conditions such as diabetic neuropathy, Parkinson ’s disease, multiple sclerosis, and dementia.  (Source: mobihealthnews)
Source: mobihealthnews - August 13, 2021 Category: Information Technology Source Type: news

Phone App Captures Measures of Functional Impairment in MS
THURSDAY, Aug. 12, 2021 -- For persons with multiple sclerosis (MS), a smartphone device captures reliable and clinically relevant measures of functional impairment, according to a study published online July 14 in the Multiple Sclerosis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2021 Category: Pharmaceuticals Source Type: news

Multiple sclerosis symptoms: The most common type of MS people could develop
MULTIPLE SCLEROSIS, known colloquially through its abbreviation MS, is a long-lasting condition that can drastically alter people's quality of life. MS has eight hallmark signs people should watch out for, and one type is more common than the others. (Source: Daily Express - Health)
Source: Daily Express - Health - August 10, 2021 Category: Consumer Health News Source Type: news

Multiple sclerosis symptoms: Most common type of MS and 8 key symptoms to watch for
MULTIPLE SCLEROSIS, known colloquially through its abbreviation MS, is a long-lasting condition that can drastically alter people's quality of life. MS has eight hallmark signs people should watch out for, and one type is more common than the others. (Source: Daily Express - Health)
Source: Daily Express - Health - August 10, 2021 Category: Consumer Health News Source Type: news

Christina Applegate Announces She Has Multiple Sclerosis
TUESDAY, Aug. 10, 2021 -- Emmy award-winning actress Christina Applegate revealed Monday night that she is battling multiple sclerosis. She is perhaps best known for her starring roles in " Married With Children, " " Dead to Me " and " Samantha Who? " " A... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 10, 2021 Category: General Medicine Source Type: news

Christina Applegate multiple sclerosis diagnosis: What are the warning signs?
Actress Christina Applegate revealed a recent multiple sclerosis diagnosis to fans on Monday, but what is the chronic disease and what... (Source: Reuters: Health)
Source: Reuters: Health - August 10, 2021 Category: Consumer Health News Source Type: news

Christina Applegate reveals multiple sclerosis diagnosis
The “Dead to Me” star has already beaten breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - August 10, 2021 Category: Consumer Health News Source Type: news

Christina Applegate reveals multiple sclerosis diagnosis
Christina Applegate has been diagnosed with multiple sclerosis. (Source: Reuters: Health)
Source: Reuters: Health - August 10, 2021 Category: Consumer Health News Source Type: news